BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23564620)

  • 1. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.
    Krahn MD; Bremner KE; Alibhai SM; Ni A; Tomlinson G; Laporte A; Naglie G
    Qual Life Res; 2013 Dec; 22(10):2951-62. PubMed ID: 23564620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
    Bremner KE; Mitsakakis N; Wilson L; Krahn MD
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
    Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
    Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).
    Waldmann A; Rohde V; Bremner K; Krahn M; Kuechler T; Katalinic A
    BMC Cancer; 2009 Aug; 9():295. PubMed ID: 19698163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada.
    de Oliveira C; Bremner KE; Ni A; Alibhai SM; Laporte A; Krahn MD
    J Cancer Surviv; 2014 Mar; 8(1):9-20. PubMed ID: 23975612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
    Jeong CW; Cowan JE; Broering JM; Ten Ham RMT; Wilson LS; Carroll PR; Cooperberg MR
    Eur Urol; 2019 Dec; 76(6):743-751. PubMed ID: 31345635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS).
    Tomlinson G; Bremner KE; Ritvo P; Naglie G; Krahn MD
    Med Decis Making; 2012; 32(1):11-30. PubMed ID: 21653804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).
    Avila M; Pardo Y; Castells M; Ferrer F; Boladeras A; Pera J; Prada PJ; Guix B; de Paula B; Hernandez H; Pont A; Alonso J; Garin O; Bremner K; Krahn M; Ferrer M;
    Qual Life Res; 2014 Nov; 23(9):2481-7. PubMed ID: 24789667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.
    Schmidt S; Garin O; Pardo Y; Valderas JM; Alonso J; Rebollo P; Rajmil L; Garcia-Forero C; Ferrer M;
    Qual Life Res; 2014 Oct; 23(8):2169-81. PubMed ID: 24748557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication.
    Bosch JL; Halpern EF; Gazelle GS
    Med Decis Making; 2002; 22(5):403-9. PubMed ID: 12365482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of disease-specific and generic utility instruments in prostate cancer patients.
    Krahn M; Bremner KE; Tomlinson G; Ritvo P; Irvine J; Naglie G
    Qual Life Res; 2007 Apr; 16(3):509-22. PubMed ID: 17091359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation and cultural adaptation of Health Utilities Index (HUI) Mark 2 (HUI2) and Mark 3 (HUI3) with application to survivors of childhood cancer in Brazil.
    Shimoda S; de Camargo B; Horsman J; Furlong W; Lopes LF; Seber A; Barr RD
    Qual Life Res; 2005 Jun; 14(5):1407-12. PubMed ID: 16047515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys.
    Zamora V; Garin O; Pardo Y; Pont À; Gutiérrez C; Cabrera P; Gómez-Veiga F; Pijoan JI; Litwin MS; Ferrer M;
    Value Health; 2021 Nov; 24(11):1676-1685. PubMed ID: 34711369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term quality of life among localised prostate cancer survivors: QALIPRO population-based study.
    Kerleau C; Guizard AV; Daubisse-Marliac L; Heutte N; Mercier M; Grosclaude P; Joly F;
    Eur J Cancer; 2016 Aug; 63():143-53. PubMed ID: 27318002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study.
    Darwish-Yassine M; Berenji M; Wing D; Copeland G; Demers RY; Garlinghouse C; Fagerlin A; Newth GE; Northouse L; Holmes-Rovner M; Rovner D; Sims J; Wei JT
    J Cancer Surviv; 2014 Mar; 8(1):121-30. PubMed ID: 24214413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients.
    Rashidi AA; Anis AH; Marra CA
    Health Qual Life Outcomes; 2006 Apr; 4():25. PubMed ID: 16626489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review and meta-analysis of prostate cancer utilities.
    Bremner KE; Chong CA; Tomlinson G; Alibhai SM; Krahn MD
    Med Decis Making; 2007; 27(3):288-98. PubMed ID: 17502448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of utility index of quality of life (QOL) in prostate cancer patients: comparison of QOL utility index EuroQol-5D (EQ-5D) and visual analogue scale (VAS) with health-related QOL questionnaires SF-36 and EPIC].
    Akakura K; Matsuzaki K; Kobayashi T; Kitoh H; Mizoguchi K; Tomikawa G; Takura T; Kawabuchi K
    Nihon Hinyokika Gakkai Zasshi; 2011 Jan; 102(1):9-13. PubMed ID: 21520631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer.
    Krahn M; Ritvo P; Irvine J; Tomlinson G; Bezjak A; Trachtenberg J; Naglie G
    J Clin Epidemiol; 2000 Sep; 53(9):920-30. PubMed ID: 11004418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.